What we do
For over 125 years, Roche has been a global leader in healthcare innovation, committed to improving lives by advancing science and providing access to life-saving medicines and diagnostics. Operating in Aotearoa New Zealand through Roche Pharmaceuticals and Roche Diagnostics, the organisation focuses on early detection and treatment of serious illnesses such as cancer, infectious diseases, and cardiovascular conditions. With a strong emphasis on personalised healthcare, Roche tailors solutions to effectively prevent, diagnose, and treat diseases, transforming the lives of thousands of New Zealanders. Roche's commitment to innovation is demonstrated through its significant investment in clinical trials, contributing over $30 million to local research and development in the past five years. This effort has provided access to advanced treatments for over 1000 New Zealanders, underscoring their dedication to delivering sustainable healthcare solutions. With nearly 100 employees in New Zealand and 27 medicines available locally, Roche continues to shape the future of healthcare by ensuring the right medicines reach the right patients at the right time.
Overview of our offering
- Cancer diagnostics: Providing cutting-edge diagnostic tools and solutions to detect and manage various types of cancer, enabling accurate and early diagnosis.
- Clinical support systems: Implementing advanced clinical support technologies to assist healthcare professionals in making informed decisions, improving patient care.
- Community pharmacy and POS: Enhancing the capabilities of community pharmacies with point-of-sale solutions and integrated services that streamline operations and improve patient engagement.
- Consumer apps and health monitoring: Developing user-friendly applications and monitoring tools that empower individuals to actively manage their health and wellness.
- Diagnostics and genomics: Innovating in diagnostic services and genomic testing to offer personalised insights, aiding in tailoring treatments to individual patients.
- Personalised patient support: Offering bespoke patient support programmes to improve treatment adherence and quality of life for those with chronic or complex health conditions.
Target customer: Roche New Zealand’s primary customers include healthcare providers, hospitals, laboratories, and patients with complex or chronic health conditions who require access to advanced diagnostics and cutting-edge treatments.